Targeted Metabolomics for Oxylipins and Endocannabinoids to Inform About a Role for Inflammation in Alzheimer's Disease
Research Grant
Administered By
Psychiatry & Behavioral Sciences, Behavioral Medicine & Neurosciences
Awarded By
Foundation for the National Institutes of Health
Start Date
August 26, 2025
End Date
March 1, 2027
Administered By
Psychiatry & Behavioral Sciences, Behavioral Medicine & Neurosciences
Awarded By
Foundation for the National Institutes of Health
Start Date
August 26, 2025
End Date
March 1, 2027